Lanxess Equity: Navigating Headwinds with Strategic Price Hikes

Despite a price target cut and short-selling pressure, Lanxess implements aggressive price hikes to counter profit declines, with recovery expected in H2 2026.

Despite a recent price target cut from analysts at Berenberg, shares of the specialty chemicals group Lanxess managed to close the prior week in positive territory. This apparent contradiction highlights a company aggressively implementing price increases in an effort to steer through a challenging turnaround period.

Analyst Caution Amid Speculative Pressure

Berenberg maintained its "Hold" rating on Lanxess stock but reduced its target price from €18 to €17. The bank's analysts pointed to geopolitical tensions in the Middle East, which negatively impacted the start of the year, as a key reason for the downward revision. Further pressure is indicated by current data on short-selling positions, which reveal that speculative investors continue to bet on a declining share price. This activity suggests that confidence in a rapid recovery for the company remains limited.

A Broad-Based Pricing Strategy Takes Shape

In response to a difficult market environment, Lanxess management has launched a comprehensive pricing initiative. By the end of March, the company had raised prices by up to 30% for inorganic pigments and for products within its Microbial Control unit—including active ingredients, preservatives, and disinfectants. This move followed shortly after similar price increases were enacted for flame retardants, plasticizers, and specialty additives.

These decisive actions are a direct countermeasure to significant profit pressures. The company faced substantial headwinds in 2025 from competitive pricing out of Asia and highly volatile raw material costs. These challenges were reflected in the full-year results: group sales fell by nearly 11% to €5.67 billion, while adjusted EBITDA dropped 16.9% to €510 million. Consequently, the dividend was slashed to a symbolic €0.10 per share. A silver lining was provided by the sale of the Urethane Systems business segment, which helped reduce net financial debt by 15% to approximately €2.02 billion.

Management Foresees Gradual Recovery

CEO Matthias Zachert has tempered expectations for an immediate rebound. He anticipates that positive momentum will not materialize before the summer months at the earliest. This potential uplift is partly tied to the German federal government's infrastructure package, which is expected to stimulate demand within key customer industries for Lanxess.

Beyond pricing power, the company has also initiated permanent cost-reduction measures aimed at saving around €100 million. The financial outlook for 2026 underscores the prevailing uncertainty, with guidance for adjusted EBITDA set within a wide range of €450 million to €550 million. Whether Lanxess achieves the upper or lower half of this forecast will hinge on two critical factors: the market's acceptance of its new pricing structure and the anticipated demand recovery in the latter half of the year.